Lifelines COVID-19 cohort: investigating COVID-19 infection and its health and societal impacts in a Dutch population-based cohort.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
17 03 2021
Historique:
entrez: 19 3 2021
pubmed: 20 3 2021
medline: 24 3 2021
Statut: epublish

Résumé

The Lifelines COVID-19 cohort was set up to assess the psychological and societal impacts of the COVID-19 pandemic and investigate potential risk factors for COVID-19 within the Lifelines prospective population cohort. Participants were recruited from the 140 000 eligible participants of Lifelines and the Lifelines NEXT birth cohort, who are all residents of the three northern provinces of the Netherlands. Participants filled out detailed questionnaires about their physical and mental health and experiences on a weekly basis starting in late March 2020, and the cohort consists of everyone who filled in at least one questionnaire in the first 8 weeks of the project. FINDINGS TO DATE: >71 000 unique participants responded to the questionnaires at least once during the first 8 weeks, with >22 000 participants responding to seven questionnaires. Compiled questionnaire results are continuously updated and shared with the public through the Corona Barometer website. Early results included a clear signal that younger people living alone were experiencing greater levels of loneliness due to lockdown, and subsequent results showed the easing of anxiety as lockdown was eased in June 2020. Questionnaires were sent on a (bi)weekly basis starting in March 2020 and on a monthly basis starting July 2020, with plans for new questionnaire rounds to continue through 2020 and early 2021. Questionnaire frequency can be increased again for subsequent waves of infections. Cohort data will be used to address how the COVID-19 pandemic developed in the northern provinces of the Netherlands, which environmental and genetic risk factors predict disease susceptibility and severity and the psychological and societal impacts of the crisis. Cohort data are linked to the extensive health, lifestyle and sociodemographic data held for these participants by Lifelines, a 30-year project that started in 2006, and to data about participants held in national databases.

Identifiants

pubmed: 33737436
pii: bmjopen-2020-044474
doi: 10.1136/bmjopen-2020-044474
pmc: PMC7977080
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e044474

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Br J Clin Psychol. 2004 Sep;43(Pt 3):245-65
pubmed: 15333231
Lancet. 2020 May 16;395(10236):1545-1546
pubmed: 32359402
PLoS One. 2015 Sep 02;10(9):e0137203
pubmed: 26333164
Qual Life Res. 2014 Apr;23(3):791-803
pubmed: 23686556
JAMA Psychiatry. 2020 Aug 1;77(8):842-851
pubmed: 32236498
JACC Case Rep. 2020 Jul 15;2(9):1414-1418
pubmed: 32835287
BMJ. 2020 Mar 26;368:m1211
pubmed: 32217624
Int J Epidemiol. 2015 Aug;44(4):1172-80
pubmed: 25502107
BMJ Open. 2015 Aug 28;5(8):e006772
pubmed: 26319774
Eur J Epidemiol. 2020 Feb;35(2):157-168
pubmed: 32100173
Eur J Hum Genet. 2020 Jun;28(6):715-718
pubmed: 32404885
Nat Med. 2020 Jul;26(7):1037-1040
pubmed: 32393804
J Am Med Dir Assoc. 2012 Jul;13(6):546-51
pubmed: 22579590

Auteurs

Katherine Mc Intyre (K)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Pauline Lanting (P)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Patrick Deelen (P)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Department of Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.

Henry H Wiersma (HH)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Judith M Vonk (JM)

Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Anil P S Ori (APS)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Soesma A Jankipersadsing (SA)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Robert Warmerdam (R)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Irene van Blokland (I)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Floranne Boulogne (F)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Marjolein X L Dijkema (MXL)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Johanna C Herkert (JC)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Annique Claringbould (A)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Olivier Bakker (O)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Esteban A Lopera Maya (EA)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Ute Bültmann (U)

Department of Health Sciences, Community and Occupational Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Alexandra Zhernakova (A)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Sijmen A Reijneveld (SA)

Department of Health Sciences, Community and Occupational Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Elianne Zijlstra (E)

Department of Health Sciences, Community and Occupational Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Morris A Swertz (MA)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Sandra Brouwer (S)

Department of Health Sciences, Community and Occupational Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Raun van Ooijen (R)

Department of Health Sciences, Community and Occupational Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Viola Angelini (V)

Faculty of Economics and Business, University of Groningen, Groningen, The Netherlands.

Louise H Dekker (LH)

Faculty of Economics and Business, University of Groningen, Groningen, The Netherlands.
Department of Nephrology, University Medical Center Groningen, Groningen, The Netherlands.

Anna Sijtsma (A)

Lifelines Cohort Study, Groningen, The Netherlands.

Sicco A Scherjon (SA)

Department of Obstetrics and Gynaecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Cisca Wijmenga (C)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
K.G. Jebsen Coeliac Disease Research Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Jackie A M Dekens (JAM)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Center of Development and Innovation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Jochen Mierau (J)

Faculty of Economics and Business, University of Groningen, Groningen, The Netherlands.
Aletta Jacobs School of Public Health, University of Groningen, Groningen, The Netherlands.

H Marike Boezen (HM)

Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Lude Franke (L)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands l.h.franke@umcg.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH